Subscribe to our twitter feeds Subscribe to email digest Subscribe to email alerts

sort by: Most Recent  [   Popular Today  |   Popular This Week  ]
·       Clinical stage tropoelastin platform with potential applications in aesthetics, scar remodeling and surgical wound repair ·       Introduces key ‘youth protein’ tropoelastin to Allergan’s Juvederm dermal filler portfolio ·       Provides infrast

announced by Elastagen Pty Ltd over 3 years , category: Medical & Pharmaceutical
Elastagen Pty Ltd, a clinical stage medical company developing products based on a proprietary recombinant human tropoelastin platform technology, announces the closing of a A$13 million Series B financing round.